Evidence map›Paper›PMID 40330125›Full record

ArticleEngineering (Beijing, China)2025

Acoustofluidics-Based Intracellular Nanoparticle Delivery.

Zhishang Li, Zhenhua Tian, Jason N Belling, Joseph T Rich, Haodong Zhu, Zhehan Ma, Hunter Bachman, Liang Shen, Yaosi Liang, Xiaolin Qi and 11 more

Abstract read
In one paragraph

Article in Engineering (Beijing, China), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Zhishang LiCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou 310058, China.
Zhenhua TianDepartment of Mechanical Engineering, Virginia Tech, Blacksburg, VA 24061, USA.
Jason N BellingCalifornia NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Joseph T RichDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA.
Haodong ZhuDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA.
Zhehan MaDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA.
Hunter BachmanDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA.
Liang ShenDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA.
Yaosi LiangDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA.
Xiaolin QiDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA.
Liv K HeidenreichCalifornia NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Yao GongCalifornia NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Shujie YangDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA.
Wenfen ZhangCollege of Chemistry and Molecular Engineering, Zhengzhou University, Zhengzhou 450001, China.
Peiran ZhangDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA.
Yingchun FuCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou 310058, China.
Yibin YingCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou 310058, China.
Steven J JonasCalifornia NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Yanbin LiDepartment of Biological and Agricultural Engineering, University of Arkansas, Fayetteville, AR 72701, USA.
Paul S WeissCalifornia NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Tony J HuangDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA.

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Nanoscience-Inspired Acoustofluidic Assembly Lines for Gene and Cellular TherapiesDP5OD028181 · OD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JONAS, STEVEN JOHN · 2019 to 2023
$1.9M
Development of a digital acoustofluidic system for automating liquid handling in biomedical researchR01GM141055 · NIGMS · DUKE UNIVERSITY · PI HUANG, TONY JUN · 2021 to 2024
$1.9M
Site-Specific Correction of Sickle Cell Disease Using Acoustofludic Gene DeliveryF31HL149356 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BELLING, JASON NATHANIEL · 2019 to 2020
$71k
NCATS NIH HHS UL1 TR001881NHLBI NIH HHS F31 HL149356NIGMS NIH HHS R01 GM141055NIH HHS DP5 OD028181
6 · The paper itself

Abstract

Controlled intracellular delivery of biomolecular cargo is critical for developing targeted therapeutics and cell reprogramming. Conventional delivery approaches (e.g., endocytosis of nano-vectors, microinjection, and electroporation) usually require time-consuming uptake processes, labor-intensive operations, and/or costly specialized equipment. Here, we present an acoustofluidics-based intracellular delivery approach capable of effectively delivering various functional nanomaterials to multiple cell types (e.g., adherent and suspension cancer cells). By tuning the standing acoustic waves in a glass capillary, our approach can push cells in flow to the capillary wall and enhance membrane permeability by increasing membrane stress to deform cells via acoustic radiation forces. Moreover, by coating the capillary with cargo-encapsulated nanoparticles, our approach can achieve controllable cell-nanoparticle contact and facilitate nanomaterial delivery beyond Brownian movement. Based on these mechanisms, we have successfully delivered nanoparticles loaded with small molecules or protein-based cargo to U937 and HeLa cells. Our results demonstrate enhanced delivery efficiency compared to attempts made without the use of acoustofluidics. Moreover, compared to conventional sonoporation methods, our approach does not require special contrast agents with microbubbles. This acoustofluidics-based approach creates exciting opportunities to achieve controllable intracellular delivery of various biomolecular cargoes to diverse cell types for potential therapeutic applications and biophysical studies.

Indexed as

AcoustofluidicsMetal-organic frameworksNanocarriersSonoporation

Identifiers

PMID40330125
PMCPMC12054690

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.